About Genetiks
Our Vision & Mission
History
Administrative Structure
Quality Policy
Certificates
Licences
Publications
Proceedings
All Services
OnkoGENETiKS
General Information
Next Generation Oncology
CGP (Comprehensive Genomic Profiling)
Liquid Biopsy
Hereditary Cancer Panels
Breast and Ovary Cancer Panel
Conventional Oncology Tests
ReproGenetiks
Preimplantation Genetic Tests (PGT)
Prenatal Tests
Preconceptional Genetic Testing
Sperm FISH
TUNNEL Test (Sperm fragmentation)
Peripheral Karyotyping
Y Microdeletion
Thrombophilia panel
Endometrial Receptivity & Microbiome Analysis
Rare/Pediatric Disorders
CES (Clinical exome sequencing)
WES (Whole exome sequencing)
WGS (Whole genome sequencing)
Microarray
Microdeletion&Duplication Syndromes
Mutation Analysis
Gene Sequencing
PharmacoGENETiKS
Drug sensitivity/Dose setting
Toxicity/Targeted therapy
Toxicity
Immunotherapy/Targeted Therapy
Wellness
Cardiovascular Risk Panel
NutriGenetiks
Sport Genetics
Genetic Counselling
Types of Genetic Disorders
What is the Genetic Counseling Process?
Who Should Consider Genetic Counseling?
Genetic Counseling Specialties
Request Forms
Consent Forms
Sample Sending
ABOUT US
SERVICES
FIND TEST
FORMS
ONLINE REPORTS
Test Search
News
Contact
ACGH technique is currently used to identify chromosomal diseases that cannot be detected by chromosome analysis (microdeletion syndromes, etc.) and to rapidly evaluate chromosomal disorders. It is also used in the identification of chromosomal diseases identified but not identified in chromosome analysis.
In addition, 60-70% of first trimester pregnancy losses are detected chromosomal disorders such as aneuploidy, triploidy and uniparental dysomy (UPD). Problems such as failure of cell culture and length of time of obtaining maternal contamination are frequently encountered in chromosome analysis made from tissue samples belonging to pregnancy losses by using classical cytogenetic methods. Therefore, it is recommended to examine the aborted materials with aCGH technique in pregnancy losses.
In parallel with these studies, molecular karyotyping is applied by aCG method in our center and 315k (CytoScan® Optima Suite) and 750k (CytoScan® 750K Array Kit) are developed by Affymetrix.
CytoScan® Optima Suite is especially designed for prenatal and perinatal period and is designed to have higher resolution for 396 microdeletion zones.
Terrace Fulya Center 2, Teşvikiye, Hakkı Yeten Cd. No:13 Kat M4, 34365 Şişli / İstanbul / Turkey
©2024 Genetiks. All rights reserved.